Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > $ 10.8 M & Baxter mention.

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Nov 02, 2022 1:26pm

300 Views

Post# 35067005

RE:$ 10.8 M & Baxter mention.

Looks as though the company exercised their option on over-allotment, because the issue was oversubscribed?

If so, it sure seems like a healthy raise in this kind of market. And only 7% on the debentures? Unheard of in today's interest rate climate. Seems like the holders are more interested in the underlying equity, than in the interest they will earn, or in any potntial risk they might be assuming.

I wonder what that portends after we get through the post-financing hang-over period?

MM

"Pretty certain there's no over allotment." - BSW circa last week

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter